HomeHealth NewsGLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach...

GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues

January 22, 2025

- Advertisement -

A new study compares the risks and benefits of using GLP-1 medications. Iuliia Burmistrova/Getty Images

The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss has been greatly increasing.
Past studies show there are positive and negative side effects from GLP-1 medications.
A new study reports that GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered addiction risk.
Scientists also confirmed that the use of these medications…

- Advertisment -